Ulipristal acetate resembles mifepristone in modulating human fallopian tube function

Area of Science:

• Reproductive biology
• Pharmacology
• Gynecology

Background:

• Ulipristal acetate (UPA) and mifepristone are emergency contraceptives primarily acting by inhibiting ovulation.
• Limited information exists regarding their impact on human Fallopian tube function.

Purpose of the Study:

• To investigate the effects of UPA and mifepristone on ciliary beat frequency and muscular contractions in the human Fallopian tube.
• To explore the potential mechanisms of action, including effects on progesterone receptor expression.

Main Methods:

• In vitro study utilizing human Fallopian tube samples from 11 women.
• Treatment with varying concentrations of UPA and mifepristone.
• Assessment of ciliary beat frequency, smooth muscle contractility, and mRNA expression of key genes (progesterone receptor, glycodelin, adrenomedullin).

Main Results:

• Both UPA and mifepristone demonstrated a dose-dependent suppression of ciliary beat frequency.
• Significant reduction in smooth muscle tone, amplitude, and frequency of contractions was observed with higher doses.
• UPA treatment modulated the mRNA expression of progesterone receptor, glycodelin, and adrenomedullin.

Conclusions:

• UPA, similar to mifepristone, inhibits human Fallopian tube ciliary and muscular activity, likely via tubal progesterone receptor agonism.
• The clinical significance of these tubal effects for contraceptive efficacy requires further investigation.